Kazuki Gohara Akihito Okazaki Yoshihiro Takeda Keiichi Iwasa Kazuhiko Shibata
10.1016/j.rmcr.2021.101469
Respir Med Case Rep
2021 Jul 8;33:101469.
alk, anaplastic lymphoma kinase cr, complete remission ct, computed tomography complete remission ebus-tbna, endobronchial ultrasound-guided transbronchial needle aspiration egfr, epidermal growth factor receptor ici, immune checkpoint inhibitors immunotherapy lung adenocarcinoma nlr, neutrophil-to-lymphocyte ratio nsclc, non-small cell lung cancer os, overall survival pd-l1, programmed death-ligand 1 pr, partial response pembrolizumab rr, response rate tps, tumor proportion score
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/34401305/
Case Reports
PMC8348966
34401305
Complete remission of advanced lung adenocarcinoma with first-line pembrolizumab monotherapy: Two case reports
2021